The project will be funded as part of our $5 million commitment to fund research into early detection and screening Toronto – July 2024 Pancreatic cancer is the world’s toughest cancer – the 5-year relative survival rate is just over 10 percent. Most...
Stand Up To Cancer and Pancreatic Cancer North America: Our Commitment To Pancreatic Cancer Vaccine Research Thursday, June 1, 2023 Today marks a significant milestone in our continued efforts to meaningfully change pancreatic cancer outcomes. Pancreatic Cancer...
PCC Talks mRNA Vaccine Trial Phase I Results with CTV News Toronto Friday, May 19, 2023 Community advocate and pancreatic cancer survivor, Joel Weiss spoke with CTV News Toronto reporter Pauline Chan to discuss the mRNA pancreatic cancer vaccine trial....
Past PCC Board Chair, Dr. Anish Kirpalani, shares what Canadians need to know about pancreatic cancer with CTV Morning Live Saskatoon Friday, November 25, 2022 As part of PCC’s Pancreatic Cancer Awareness Month efforts, Past Board Chair, Dr. Anish Kirpalani,...
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
Recent Comments